Riskpilot← Back to searchSign inGet full accessMedicosmos A/S
A/SActiveCVR 43752375Rørvangsvej 30Activities of holding companies · NACE 6421Est. 2022— employees
Revenue 2025
DKK 0
EBITDA margin
—
+386% vs 2024
Equity ratio
100.0%
Financial strength
Net profit 2025
DKK 1,7B
+104% vs 2024
| Revenue | DKK 0 | — |
| EBITDA | DKK 83K | +386% |
| Net profit | DKK 1,7B | +104% |
| Total assets | DKK 2,3B | +24% |
| Equity | DKK 2,3B | +24% |
| Employees | — | — |
Legal name
Medicosmos A/S
CVR number
43752375
Legal form
Aktieselskab
NACE code
6421 · Activities of holding companies
Founded
29. december 2022
Share capital
DKK 6.000.000
Employees
—
VAT registered
No
Audit selected
Yes
Last report
2025-04-30
Financial year
January – December
Signatory rights
Selskabet tegnes af den samlede bestyrelse, eller af et medlem af direktionen og et medlem af bestyrelsen i forening, eller af Tobias Sidelmann Christensen alene.
Company purpose
Selskabets formål er at erhverve, besidde, administrere og sælge ejerandele og andre direkte eller indirekte interesser i selskaber eller forretning, uanset form, som driver virksomhed med udvikling, produktion og handel med farmaceutiske, kemiske og tekniske produkter, anlæg og lignende, og at drive anden virksomhed, der efter bestyrelsens skøn er forbundet dermed.
Address
Rørvangsvej 30
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | — | 0 | 0 |
| Staff expenses | -0 | -0 | -0 |
| EBITDA | -16 | -29 | 83 |
| Depreciation & amort. | -0 | -0 | -0 |
| EBIT | -16 | -29 | 83 |
| Net financials | 128.643 | 808.682 | 1.652.204 |
| Profit before tax | 128.627 | 808.654 | 1.652.286 |
| Tax | -4 | -6 | 19 |
| Net profit | 128.631 | 808.660 | 1.652.267 |
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total assets | 1.031.425 | 1.831.653 | 2.273.374 |
| Equity | 1.031.409 | 1.831.559 | 2.273.234 |
| Long-term debt | 0 | 0 | 0 |
| Short-term debt | 16 | 94 | 140 |
| Total debt | 16 | 94 | 140 |
EBITDA margin
8300000.0%
This company
15.8%
Market median
+52531546% vs market
20232025
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20232025
Return on equity
72.7%
This company
18.4%
Market median
+295% vs market
20232025
Net profit margin
165226700000.0%
This company
8.1%
Market median
+2039835802369% vs market
20232025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20232025
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20232025
- Annual report 2025Filed via CVR / Virk · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via CVR / Virk · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via CVR / Virk · Period 2022-05-01 – 2023-04-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
TS Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
HP Management | Management | 2023 | — | — |
RG Management | Management | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2022 | — | — | |
| Board of Directors | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Medicosmos Holding A/S | Company | 100.0% | 100.0% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
ANTOAX HOLDING A/S
Medicosmos A/S Board members of Medicosmos A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tobias Sidelmann Christensen | Chief Executive Officer | 0 companies |
| Henrik Parker | Management | 0 companies |
| Robert Guglielmetti | Management | 0 companies |
| Lars Christensen | Chairman | 0 companies |
| Milena Jordanova Olsen | Board of Directors | 0 companies |